全球基因組學市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

基因組學市場預計將從 2025 年的 506.7 億美元成長到 2034 年的 2,077 億美元，2026 年至 2034 年的複合年成長率為 16.97%。

由於DNA定序技術的進步和定序成本的下降，全球基因組學市場正經歷顯著擴張。精準醫療、藥物研發、農業和生物技術等領域的應用正在拓展市場範圍。各國政府和私人機構正大力投資基因組學研究舉措，旨在改善疾病診斷和治療效果。將基因組學融入臨床實踐的趨勢正持續在全球加速發展。

關鍵成長要素包括慢性病盛行率上升、對個人化醫療的需求日益成長以及新一代定序技術的快速創新。基因組學在識別遺傳疾病和指南標靶治療方面發揮著至關重要的作用。研究合作的拓展和資金投入的增加也在推動市場成長。基因編輯技術和生物資訊學工具等技術的進步正在進一步提升相關能力。

展望未來，隨著數據分析和基於人工智慧的基因組解讀準確性的提高，基因組學市場預計將迎來強勁成長。新興經濟體精準醫療計畫的拓展可望創造新的機會。倫理和監管框架將持續發展，以支持創新。基因治療和分子診斷領域的持續突破預計將塑造全球基因組學市場的未來前景。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球基因體學市場：依應用與技術分類

• 市場分析、洞察與預測
• 功能基因體學
• 表觀基因
• 通路分析
• 生物標記發現

第5章 全球基因體學市場：依技術分類

• 市場分析、洞察與預測
• 順序
• PCR
• 流式細胞技術
• 微陣列
• 其他

第6章：全球基因體學市場：依交付成果分類

• 市場分析、洞察與預測
• 產品
• 服務

第7章 全球基因體學市場：依最終用途分類

• 市場分析、洞察與預測
• 臨床研究
• 學術機構及政府機構
• 醫院和診所
• 製藥和生物技術公司
• 其他

第8章 全球基因體學市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和分銷通路合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Agilent Technologies
  • Bio-Rad Laboratories Inc
  • BGI Genomics
  • Color Genomics Inc
  • Danaher Corporation
  • Eppendorf AG
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd
  • GE Healthcare
  • Illumina Inc
  • Myriad Genetics Inc
  • Oxford Nanopore Technologies

The Genomics Market size is expected to reach USD 207.70 Billion in 2034 from USD 50.67 Billion (2025) growing at a CAGR of 16.97% during 2026-2034.

The Global Genomics Market has witnessed significant expansion driven by advancements in DNA sequencing technologies and declining sequencing costs. Applications in precision medicine, drug discovery, agriculture, and biotechnology have broadened the market scope. Governments and private organizations are investing heavily in genomic research initiatives to improve disease diagnosis and treatment outcomes. The integration of genomics into clinical practice continues to accelerate adoption globally.

Key growth drivers include the increasing prevalence of chronic diseases, rising demand for personalized healthcare, and rapid innovation in next-generation sequencing technologies. Genomics plays a crucial role in identifying genetic disorders and guiding targeted therapies. Growing research collaborations and funding support are also strengthening market growth. Technological advancements such as gene editing and bioinformatics tools further enhance capabilities.

Looking forward, the genomics market is expected to grow at a strong pace as data analytics and artificial intelligence improve genomic interpretation. Expansion of precision medicine programs in emerging economies will create new opportunities. Ethical and regulatory frameworks will continue evolving to support innovation. Continued breakthroughs in gene therapy and molecular diagnostics will shape the future of the global genomics market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application & Technology

• Functional Genomics
• Epigenomics
• Pathway Analysis
• Biomarker Discovery

By Technology

• Sequencing
• PCR
• Flow Cytometry
• Microarrays
• Other Technologies

By Deliverables

• Products
• Services

By End-use

• Clinical Research
• Academic & Government Institutes
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Other End Users

COMPANIES PROFILED

• Agilent Technologies, BioRad Laboratories Inc, BGI Genomics, Color Genomics Inc, Danaher Corporation, Eppendorf AG, Eurofins Scientific, F HoffmannLa Roche Ltd, GE Healthcare, Illumina Inc, Myriad Genetics Inc, Oxford Nanopore Technologies

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL GENOMICS MARKET: BY APPLICATION & TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Application & Technology
• 4.2. Functional Genomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Epigenomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Pathway Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Biomarker Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GENOMICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. PCR Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Flow Cytometry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Microarrays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Technologies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GENOMICS MARKET: BY DELIVERABLES 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Deliverables
• 6.2. Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL GENOMICS MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Clinical Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Academic & Government Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL GENOMICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Application & Technology
  • 8.2.2 By Technology
  • 8.2.3 By Deliverables
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Application & Technology
  • 8.3.2 By Technology
  • 8.3.3 By Deliverables
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Application & Technology
  • 8.4.2 By Technology
  • 8.4.3 By Deliverables
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Application & Technology
  • 8.5.2 By Technology
  • 8.5.3 By Deliverables
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Application & Technology
  • 8.6.2 By Technology
  • 8.6.3 By Deliverables
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL GENOMICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Agilent Technologies
  • 10.2.2 Bio-Rad Laboratories Inc
  • 10.2.3 BGI Genomics
  • 10.2.4 Color Genomics Inc
  • 10.2.5 Danaher Corporation
  • 10.2.6 Eppendorf AG
  • 10.2.7 Eurofins Scientific
  • 10.2.8 F. Hoffmann-La Roche Ltd
  • 10.2.9 GE Healthcare
  • 10.2.10 Illumina Inc
  • 10.2.11 Myriad Genetics Inc
  • 10.2.12 Oxford Nanopore Technologies